Pettersson, Goteborg
Andreas Pettersson, Goteborg SE
Patent application number | Description | Published |
---|---|---|
20090325122 | DRILL TEMPLATE ARRANGEMENT - A drilling assembly is provided for drilling a hole into a zygoma of a patient. The assembly can comprise a template, an extension unit, a drill guide unit, and first and second drills. The template can be configured for orientation within a patient's mouth and can comprise a guide sleeve having a longitudinal axis extending towards the zygoma when fitted on the patient. The extension unit can include a central bore and be slideably received within the guide sleeve. The drill guide unit can also include a central bore of a different diameter than that of the extension unit. The first drill can be slideably received within the central bore of the guide sleeve. The second drill can have an outer diameter different than that of the first drill and can be configured to be slideably received with the central bore of the drill guide unit. | 12-31-2009 |
20100028827 | SYSTEM AND ARRANGEMENT FOR PRODUCTION AND INSERTION OF A DENTAL BRIDGE STRUCTURE - A system comprises a computer appliance designed to receive, and to present on screen, first information transmitted from identification equipment and based on detection of a jaw bone structure. Modification information which can be introduced into the computer appliance shows a visual dental bridge structure applied on the jaw bone structure with associated teeth and dentine. Orientations for implants are also shown. The computer appliance produces a CAD file which is based on the first information and the modification information. The file is received in a stereolithography machine which issues second information which can be processed in the equipment for production of the physical template which includes through-bores for sleeves which define implant orientation. A working model is produced with the aid of the physical template. The invention also relates to an arrangement of a template produced by stereolithography and by means of information from the computer appliance. | 02-04-2010 |
20100332248 | COMPUTER IMPLEMENTED PLANNING AND PROVIDING OF MASS CUSTOMIZED BONE STRUCTURE - A computer-implemented method, a system and a computer program is disclosed, which comprise virtual planning of a medical procedure of a patient. The medical procedure comprises providing a patient configured bone structure in a body portion of the patient. Based on an input of a final result of the medical procedure, the bone structure may be modified by various tools and methods, such a bone implants, bone distractive methods, etc. Production data based on the virtual planning is generated that is configured for subsequent use in production of the bone structure or a medical product, which medical product is devised for use in the medical procedure, and devised for arrangement in the patient for facilitating the medical procedure. The virtual planning of a medical procedure comprises providing position data for a position of at least a part of a prosthesis component in relation to the body portion, and virtual planning of a modification of a boundary surface at the body portion as a function of the position data. | 12-30-2010 |
20110008751 | METHOD AND SYSTEM FOR DENTAL PLANNING AND PRODUCTION - A method and system useful for planning a dental restorative procedure of a patient and for producing at least one dental restoration or product related thereto to be used in said dental restorative procedure are disclosed. Input data from different sources, e.g. 3D data from a CT scan of a patient with a dental impression tray including a previously prepared dental impression of the patient in the patient's mouth, is matched with data from a high resolution 3D scan of the same dental impression. The resulting data is for instance matched by means of fiducial markers arranged at the dental impression tray. Thus reliable planning and production are enabled by means of the same, matched data set. In this manner the dosage to which the patient is exposed to may be reduced in comparison to previous methods. | 01-13-2011 |
20110060558 | REPOSITIONING OF COMPONENTS RELATED TO CRANIAL SURGICAL PROCEDURES IN A PATIENT - Methods, systems, and computer-readable media are disclosed herein for virtually planning a cranial guided surgery in a subject. These include, in some embodiments, generating a first data set based on input data obtained of a reference structure having a defined fixed relation to a bone structure of said subject and generating a second data set based on input data obtained of a master structure for a surgical template, where the master structure has a defined relation to said reference structure. Further, in some embodiments, a third data set for production of said surgical can be generated based on the first data send and the second data set, wherein the relation of said reference structure to said master structure is preserved. | 03-10-2011 |
Andréas Pettersson, Goteborg SE
Patent application number | Description | Published |
---|---|---|
20100028827 | SYSTEM AND ARRANGEMENT FOR PRODUCTION AND INSERTION OF A DENTAL BRIDGE STRUCTURE - A system comprises a computer appliance designed to receive, and to present on screen, first information transmitted from identification equipment and based on detection of a jaw bone structure. Modification information which can be introduced into the computer appliance shows a visual dental bridge structure applied on the jaw bone structure with associated teeth and dentine. Orientations for implants are also shown. The computer appliance produces a CAD file which is based on the first information and the modification information. The file is received in a stereolithography machine which issues second information which can be processed in the equipment for production of the physical template which includes through-bores for sleeves which define implant orientation. A working model is produced with the aid of the physical template. The invention also relates to an arrangement of a template produced by stereolithography and by means of information from the computer appliance. | 02-04-2010 |
Fredrik Pettersson, Goteborg SE
Patent application number | Description | Published |
---|---|---|
20080269286 | Disubstituted Phenylpiperidines as Modulators of Cortical Catecholaminergic Neurotransmission - The present invention relates to compounds of the formulae (4), (5) or (6), and their use in the treatment of central nervous system disorders. | 10-30-2008 |
20100179211 | DISUBSTITUTED PHENYLPYRROLIDINES AS MODULATORS OF CORTICAL CATECHOLAMINERGIC NEUROTRANSMISSION - The present invention relates to the use of compounds which increase extracellular levels of catecholamines, dopamine and norepinephrine, in cerebral cortical areas of the mammalian brain, and more specifically to the use of 3-disubstituted phenyl-1-pyrrolidinols for the treatment of central nervous system disorders. | 07-15-2010 |
20110257148 | NOVEL 1-ALKYL-3-HYDROXY-3-PHENYLAZETIDINE DERIVATIVES USEFUL AS MODULATORS OF CORTICAL CATECHOLAMINERGIC NEUROTRANSMISSION - The present invention relates to novel 3-phenyl-azetidine derivatives, useful for modulating dopamine neurotransmission and extracellular levels of catecholamines, dopamine and norepinephrine, in cerebral cortical areas of the mammalian brain, and more specifically for the treatment of central nervous system disorders. In other aspects the invention relates to pharmaceutical compositions comprising the 3-phenyl-azetidine derivatives of the invention and to the use of these compounds for therapeutic applications. X is OH; R | 10-20-2011 |
20110257241 | 3-PHENYL-3-METHOXYPYRROLIDINE DERIVATIVES AS MODULATORS OF CORTICAL CATECHOLAMINERGIC NEUROTRANSMISSION - The present invention relates to novel 3-phenyl-3-methoxy-pyrrolidine derivatives, useful for modulating extracellular levels of catecholamines, dopamine and norepinephrine, in cerebral cortical areas of the mammalian brain, and more specifically for the treatment of central nervous system disorders. In other aspects the invention relates to pharmaceutical compositions comprising the 3-phenyl-3-methoxy-pyrrolidine derivatives of the invention and to the use of these compounds for therapeutic applications. | 10-20-2011 |
20110257242 | 3-PHENYL-3-METHOXYPYRROLIDINE DERIVATIVES AS MODULATORS OF CORTICAL CATECHOLAMINERGIC NEUROTRANSMISSION - The present invention relates to novel 3-phenyl-3-methoxy-pyrrolidine derivatives, useful for modulating dopamine neurotransmission and extracellular levels of catecholamines, dopamine and norepinephrine, in cerebral cortical areas of the mammalian brain, and more specifically for the treatment of central nervous system disorders. In other aspects the invention relates to pharmaceutical compositions comprising the 3-phenyl-3-methoxy-pyrrolidine derivatives of the invention and to the use of these compounds for therapeutic applications. | 10-20-2011 |
20110281835 | NOVEL 3-PHENYL-AZETIDINE DERIVATIVES USEFUL AS MODULATORS OF CORTICAL CATECHOLAMINERGIC NEUROTRANSMISSION - The present invention relates to novel 3-phenyl-azetidine derivatives, useful for modulating extracellular levels of catecholamines, dopamine and norepinephrine, in cerebral cortical areas of the mammalian brain, and more specifically for the treatment of central nervous system disorders. In other aspects the invention relates to pharmaceutical compositions comprising the 3-phenyl-azetidine derivatives of the invention and to the use of these compounds for therapeutic applications. | 11-17-2011 |
20140135505 | 3-PHENYL-3-METHOXY-PYRROLIDINE DERIVATIVES USEFUL AS MODULATORS OF CORTICAL CATECHOLAMINERGIC NEUROTRANSMISSION - The present invention relates to novel 3-phenyl-3-methoxy-pyrrolidine derivatives, useful for modulating extracellular levels of catecholamines, dopamine and norepinephrine, in cerebral cortical areas of the mammalian brain, and more specifically for the treatment of central nervous system disorders. In other aspects the invention relates to pharmaceutical compositions comprising the 3-phenyl-3-methoxy-pyrrolidine derivatives of the invention and to the use of these compounds for therapeutic applications. | 05-15-2014 |
Knut Pettersson, Goteborg SE
Patent application number | Description | Published |
---|---|---|
20100291064 | Compounds and Methods for the Treatment of Vascular Disease - The present invention relates to a method for the treatment of vascular dysfunction, reducing ischemic pain and/or treatment of a vascular disease comprising administering a therapeutically effective amount of Annexin A5 or a functional analogue or variant thereof to a patient in need of such treatment. The vascular dysfunction, ischemic pain and/or vascular disease may be associated with impaired endothelium mediated vasodilatation, a reduced eNOS activity, and/or a reduced NO bioavailability. The patient may be suffering from a disease selected from angina pectoris, ischemic heart disease, peripheral artery disease, systolic hypertension, migraine, type 2 diabetes and erectile dysfunction. | 11-18-2010 |
20100331970 | Compounds and Methods for the Prevention or Treatment of Restenosis - A method for the prophylaxis or treatment of restenosis comprising administering a therapeutically effective amount of Annexin A5 or a functional analogue or variant thereof to a patient in need of such treatment. A method for the treatment of stenosis in a patient comprising performing an intervention for the treatment of stenosis in conjunction with administering a therapeutically effective amount of Annexin A5 or a functional analogue or variant thereof. A pharmaceutical composition comprising a therapeutically effective amount of Annexin A5 or a functional analogue or variant thereof for the prophylaxis or treatment of restenosis. A drug eluting stent, wherein the drug is Annexin A5 or a functional analogue or variant thereof, and a method of making such a stent. | 12-30-2010 |
20140037614 | THERAPEUTIC AND PROPHYLACTIC METHODS, USES AND COMPOSITIONS COMPRISING ANEXIN A5 - The present invention provides a method for the prevention and/or reduction of peri- or postoperative complications following surgical intervention, such as complications following vascular surgery, especially peripheral vascular surgery, comprising administering a therapeutically effective amount of Annexin (A5) or a functional analogue or variant thereof to a patient in need of such treatment, Also provided is a pharmaceutical composition comprising a therapeutically effective amount of Annexin (A5) or a functional analogue or variant thereof for use in the prevention and/or reduction of peri- or postoperative complications following surgical intervention, such as complications following vascular surgery, especially peripheral vascular surgery. | 02-06-2014 |
20140178410 | ANTIBODIES AGAINST PHOSPHORYLCHOLINE - The present invention relates to an antibody or antibody fragment capable of binding to phosphorylcholine and/or a phosphorylcholine conjugate, wherein the antibody or antibody fragment comprises a variable heavy chain (VH) domain and/or a variable light chain (VL) domain, and wherein—(a) the VH domain comprises an amino acid sequence that includes one, two or three complementarity determining regions (CDRs) selected from the group consisting of: a CDR1 sequence comprising an amino acid sequence having at least 25%, 50%, 75% or 100% sequence identity to the sequence of SEQ ID NO: 17; a CDR2 sequence comprising an amino acid sequence having at least 5%, 11%, 17%, 23%, 29%, 35%, 47%, 52%, 58%, 64%, 70%, 76%, 82%, 94% or 100% sequence identity to the sequence of SEQ ID NO: 18; and a CDR3 sequence comprising an amino acid sequence having at least 4%, 9%, 13%, 18%, 22%, 27%, 31%, 36%, 40%, 45%, 50%, 54%, 59%, 63%, 68%, 72%, 77%, 81%, 86%, 90%, 95% or 100% sequence identity to the sequence of SEQ ID NO: 19, 20, 21 or 22; and/or (b) the VL domain comprises an amino acid sequence that includes one, two or three complementarity determining regions (CDRs) selected from the group consisting of: a CDR4 sequence comprising an amino acid sequence having at least 5%, 11%, 17%, 23%, 29%, 35%, 47%, 52%, 58%, 64%, 70%, 76%, 82%, 94% or 100% sequence identity to the sequence of SEQ ID NO: 23 or 24; a CDR5 sequence comprising an amino acid sequence having at least 14%, 28%, 42%, 57%, 71%, 85% or 100% sequence identity to the sequence of SEQ ID NO: 25; a CDR6 sequence comprising an amino acid sequence having at least 11%, 22%, 33%, 44%, 55%, 66%, 77%, 88% or 100% sequence identity to the sequence of SEQ ID NO: 26. | 06-26-2014 |
20140193413 | ANTIBODIES BINDING TO PHOSPHORYLCHOLINE (PC) AND/OR PC CONJUGATES - The present disclosure relates to an antibody or antibody fragment capable of binding to phosphorylcholine and/or a phosphorylcholine conjugate, wherein the antibody or antibody fragment comprises a variable heavy chain (VH) domain and/or a variable light chain (VL) domain, and wherein (a) the VH domain comprises complementarity determining regions (CDRs) selected from the group consisting of: a CDR1 sequence having identity to the sequence of SEQ ID NO: 7; a CDR2 sequence having identity to the sequence of SEQ ID NO: 8; and a CDR3 sequence having identity to the sequence of SEQ ID NO: 9 or 10; and/or (b) the VL domain comprises CDRs selected from the group consisting of: a CDR4 sequence having identity to the sequence of SEQ ID NO: 11; a CDR5 sequence having identity to the sequence of SEQ ID NO: 12; a CDR6 sequence having identity to the sequence of SEQ ID NO: 13. | 07-10-2014 |
Magnus Pettersson, Goteborg SE
Patent application number | Description | Published |
---|---|---|
20120201693 | WIND TURBINE ROTOR SERVICE PLATFORM - The invention relates to a wind turbine rotor having one or more wind turbine blades mounted on a rotor hub, the blades having a tip portion and a root portion; a service platform mounted on the wind turbine rotor providing access to the blade root portion of a wind turbine blade, wherein the service platform comprises: a walkway for a wind turbine service engineer. | 08-09-2012 |